Ekadharma International Valuation
| EKAD Stock | IDR 222.00 2.00 0.91% |
At this time, the firm appears to be undervalued. Ekadharma International shows a prevailing Real Value of 266.09 per share. The current price of the firm is 222.0. Our model computes the value of Ekadharma International from reviewing the firm fundamentals such as Current Valuation of 703.3 B, profit margin of 0.14 %, and Operating Margin of 0.17 % as well as analyzing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Ekadharma International's price fluctuation is very steady at this time. Calculation of the real value of Ekadharma International is based on 3 months time horizon. Increasing Ekadharma International's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Ekadharma International's intrinsic value may or may not be the same as its current market price of 222.00, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 222.0 | Real 266.09 | Hype 222.0 |
The intrinsic value of Ekadharma International's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Ekadharma International's stock price.
Estimating the potential upside or downside of Ekadharma International Tbk helps investors to forecast how Ekadharma stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ekadharma International more accurately as focusing exclusively on Ekadharma International's fundamentals will not take into account other important factors: Ekadharma International Total Value Analysis
Ekadharma International Tbk is currently forecasted to have takeover price of 703.3 B with market capitalization of 978.28 B, debt of 19.45 B, and cash on hands of 360.66 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Ekadharma International fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
703.3 B | 978.28 B | 19.45 B | 360.66 B |
Ekadharma International Investor Information
About 81.0% of the company shares are held by company insiders. The company recorded earning per share (EPS) of 146.27. Ekadharma International last dividend was issued on the 2nd of August 2022. The entity had 5:1 split on the 22nd of August 2022. Based on the analysis of Ekadharma International's profitability, liquidity, and operating efficiency, Ekadharma International Tbk is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Ekadharma International Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ekadharma International has an asset utilization ratio of 54.04 percent. This suggests that the Company is making 0.54 for each dollar of assets. An increasing asset utilization means that Ekadharma International Tbk is more efficient with each dollar of assets it utilizes for everyday operations.Ekadharma International Ownership Allocation
Ekadharma International holds a total of 3.49 Billion outstanding shares. Ekadharma International Tbk shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 80.89 percent of Ekadharma International outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Ekadharma International Profitability Analysis
The company reported the revenue of 629.88 B. Net Income was 104.41 B with profit before overhead, payroll, taxes, and interest of 223.51 B.About Ekadharma International Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Ekadharma International Tbk. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Ekadharma International based exclusively on its fundamental and basic technical indicators. By analyzing Ekadharma International's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Ekadharma International's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ekadharma International. We calculate exposure to Ekadharma International's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ekadharma International's related companies.PT Ekadharma International Tbk, together with its subsidiaries, manufactures and markets self-adhesive tapes in Indonesia and Malaysia. PT Ekadharma International Tbk is a subsidiary of PT Ekadharma Inti Perkasa. Ekadharma International operates under Specialty Chemicals classification in Indonesia and is traded on Jakarta Stock Exchange. It employs 587 people.
8 Steps to conduct Ekadharma International's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Ekadharma International's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Ekadharma International's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Ekadharma International's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Ekadharma International's revenue streams: Identify Ekadharma International's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Ekadharma International's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Ekadharma International's growth potential: Evaluate Ekadharma International's management, business model, and growth potential.
- Determine Ekadharma International's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Ekadharma International's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in Ekadharma Stock
Ekadharma International financial ratios help investors to determine whether Ekadharma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ekadharma with respect to the benefits of owning Ekadharma International security.